Stockreport

Traws Pharma Completes First Cohort Dosed in Phase 1 Trial for COVID Therapy

Traws Pharma, Inc.  (TRAW) 
PDF Investigational travatrelvir demonstrated preclinical activity against multiple SARS-CoV-2 variants Orally administered novel protease inhibitor does not require ritona [Read more]